Krystal Biotech (KRYS) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to -$827.8 million.
- Krystal Biotech's Enterprise Value fell 3853.85% to -$827.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$827.8 million, marking a year-over-year decrease of 3853.85%. This contributed to the annual value of -$827.8 million for FY2025, which is 3853.85% down from last year.
- According to the latest figures from Q4 2025, Krystal Biotech's Enterprise Value is -$827.8 million, which was down 3853.85% from -$731.1 million recorded in Q3 2025.
- In the past 5 years, Krystal Biotech's Enterprise Value registered a high of -$343.1 million during Q3 2021, and its lowest value of -$827.8 million during Q4 2025.
- In the last 5 years, Krystal Biotech's Enterprise Value had a median value of -$504.8 million in 2023 and averaged -$512.5 million.
- Per our database at Business Quant, Krystal Biotech's Enterprise Value soared by 1938.31% in 2023 and then plummeted by 5361.84% in 2024.
- Quarter analysis of 5 years shows Krystal Biotech's Enterprise Value stood at -$438.1 million in 2021, then increased by 13.45% to -$379.2 million in 2022, then plummeted by 40.35% to -$532.2 million in 2023, then dropped by 12.28% to -$597.5 million in 2024, then crashed by 38.54% to -$827.8 million in 2025.
- Its Enterprise Value was -$827.8 million in Q4 2025, compared to -$731.1 million in Q3 2025 and -$682.0 million in Q2 2025.